首页 › 基金 › Kynam Capital Management, LP › ENGN
Kynam Capital Management, LP 对 ENGN 的持仓历史
ENGENE THERAPEUTICS INC · 医疗保健
Kynam Capital Management, LP 在 Q3 2026 的 13F 申报中披露持有 ENGN(ENGENE THERAPEUTICS INC)457,855 股,市值约 US$916K,约占其申报组合的 0.05%,在其申报持仓中市值排名第 33 位。 Kynam Capital Management, LP 最近 9 个申报季度中有 9 个季度披露了 ENGN 持仓,最早可追溯至 Q3 2024。
最后更新: 2026-11-16 · 来源: SEC EDGAR Form 13F-HR
Kynam Capital Management, LP 对 ENGN 的持仓演变
Kynam Capital Management, LP 于 Q3 2024 首次披露 ENGN 持仓:1,736,227 股(约 US$11.5M)。 该持仓在 Q3 2025 达到峰值 4,994,090 股,市值约 US$34.1M。 在 9 次申报中,Kynam Capital Management, LP 1 次增持、3 次减持、4 次保持不变。 最近一期申报(Q3 2026)显示持股 457,855 股、市值约 US$916K。 持仓曾出现大幅变动:Q4 2024 增持约 188% (随后一个季度股价下跌 33%)、Q4 2025 减持约 70% (随后一个季度股价下跌 25%)、Q2 2026 减持约 66% (随后一个季度股价上涨 16%)。
逐季持仓明细
| 季度 | 股数 | 金额 | 变化 |
|---|---|---|---|
| Q3 2024 | 1.74M | $11.46M | 新进 |
| Q4 2024 | 4.99M | $33.21M | 增持 |
| Q1 2025 | 4.99M | $22.37M | 持有 |
| Q2 2025 | 4.99M | $18.18M | 持有 |
| Q3 2025 | 4.99M | $34.11M | 持有 |
| Q4 2025 | 1.49M | $13.48M | 减持 |
| Q1 2026 | 1.36M | $9.24M | 减持 |
| Q2 2026 | 457.86K | $792.09K | 减持 |
| Q3 2026 | 457.86K | $915.71K | 持有 |
折线上的点按变动类型着色;缺失季度表示该季未申报持仓。
关于 ENGN 与 13F 数据
ENGN(ENGENE THERAPEUTICS INC)属于医疗保健行业。我们追踪的基金中还有 26 只申报持有 ENGN,申报仓位最大的包括:FCPM III SERVICES B.V. (US$19.3M), BML Capital Management, LLC (US$13.3M), ACORN CAPITAL ADVISORS, LLC (US$7.6M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。
其它持有 ENGN 的基金
- FCPM III SERVICES B.V. 9.63M 股 · $19.27M · Q3 2026
- BML Capital Management, LLC 6.67M 股 · $13.34M · Q3 2026
- ACORN CAPITAL ADVISORS, LLC 3.81M 股 · $7.62M · Q3 2026
- Nextech Invest Ltd. 2.32M 股 · $4.02M · Q2 2026
- Peapod Lane Capital LLC 1.04M 股 · $2.08M · Q3 2026
- Omega Fund Management, LLC 876.36K 股 · $1.75M · Q3 2026
- Aldebaran Capital, LLC 657.32K 股 · $1.31M · Q3 2026
- SR ONE CAPITAL MANAGEMENT, LP 747.75K 股 · $1.29M · Q2 2026
- Elmind Capital, LP 210.00K 股 · $363.30K · Q2 2026
更多关于 Kynam Capital Management, LP
常见问题
How long has Kynam Capital Management, LP held ENGN?
Kynam Capital Management, LP has disclosed ENGN holdings in 9 of the last 9 reported quarters, going back to Q3 2024.
What is Kynam Capital Management, LP's current position in ENGN?
As of Q3 2026, Kynam Capital Management, LP holds 457.86K shares of ENGN (ENGENE THERAPEUTICS INC), valued at $915.71K, representing 0.05% of its reported portfolio and ranking #33.
Has Kynam Capital Management, LP been buying or selling ENGN?
In the latest 13F filing (Q3 2026), Kynam Capital Management, LP held unchanged its position in ENGN. The position peaked in Q3 2025 at 4.99M shares.
Which other funds hold ENGN?
Other major institutional holders of ENGN include FCPM III SERVICES B.V., BML Capital Management, LLC, ACORN CAPITAL ADVISORS, LLC, among 26 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.